Effects of typical and atypical antipsychotics on human glycine transporters

Schizophrenia Research
Jacinta B WilliamsCyrille Sur

Abstract

Augmentation strategy in the treatment of schizophrenia with the NMDA receptor co-agonist glycine has demonstrated significant improvement in patient symptoms. Interestingly, the therapeutic efficacy of glycine was more consistent among patients that were not co-administered clozapine suggesting that clozapine modulates glycine levels in brain. Since cerebral glycine concentration in the vicinity of NMDA receptors is thought to be controlled by the glia expressed glycine transporter type 1 (GlyT1), the effects of several typical and atypical antipsychotics on glycine uptake were examined in human placenta choriocarcinoma (JAR) cells expressing human GlyT1a. The selectivity of these compounds was investigated by measuring their inhibitory potency at the closely related glycine transporter type 2 (GlyT2). Typical antipsychotics haloperidol, thioridazine and chlorpromazine non-selectively inhibited [(14)C]glycine uptake mediated by GlyT1a and GlyT2 with potency of 9-21 microM. The atypical antipsychotic, clozapine antagonized glycine transport by human GlyT1a with an IC(50) of 100 microM and was weaker at recombinant GlyT2. Its main metabolites, N-desmethylclozapine and clozapine N-oxide were very weak inhibitors at all glycine tr...Continue Reading

References

Jan 26, 1995·Biochimica Et Biophysica Acta·J GomezaC Aragón
Sep 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R J BaldessariniB M Cohen
Nov 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·U Heresco-LevyD Kelly
Sep 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D C JavittA Lajtha
Dec 4, 1998·Biological Psychiatry·G TsaiJ T Coyle
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·R BergeronR W Greene
Mar 4, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D Jentsch, R H Roth
Mar 17, 2000·Brain Research. Brain Research Reviews·N C Andreasen
Apr 28, 2000·The American Journal of Psychiatry·A E EvinsD C Goff
May 10, 2001·The International Journal of Neuropsychopharmacology·Uriel Heresco-Levy
Jan 25, 2002·The International Journal of Neuropsychopharmacology·D C JavittS R Zukin
May 29, 2002·Life Sciences·David W BoultonJohn S Markowitz
Jan 24, 2003·Expert Opinion on Therapeutic Targets·Robert J Vandenberg, Karin R Aubrey
Mar 21, 2003·Nature·Yi NongMichael W Salter
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Cyrille SurP Jeffrey Conn

❮ Previous
Next ❯

Citations

Aug 22, 2009·Neuroscience and Biobehavioral Reviews·Viviane Labrie, John C Roder
Feb 24, 2007·Neurochemistry International·Solveig Henjum, Bjørnar Hassel
Apr 17, 2012·Journal of Psychiatric Research·Jaromir HonsJan Libiger
Apr 28, 2009·Pharmacology & Therapeutics·Toshihiro DohiNorimitsu Morioka
Feb 1, 2011·Therapeutic Advances in Psychopharmacology·James M Stone
Mar 8, 2007·Journal of Pharmacological Sciences·Kenji MaedaKiyofumi Yamada
Feb 25, 2018·Pharmaceutical Research·Nino TetroSara Eyal
Feb 27, 2019·European Archives of Psychiatry and Clinical Neuroscience·Luk MskChen Eyh
Mar 7, 2006·Clinical Neuropharmacology·Constantin TranulisDavid Gourion
Feb 9, 2006·Journal of Neural Transmission·G Ceresoli-BorroniR Schwarcz
Apr 11, 2006·Journal of Neural Transmission·S-J TsaiY-J Liou
Jan 18, 2006·Health Promotion Practice·Garth N GrahamGeorgia Buggs
May 7, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N S Kolomeets
Nov 3, 2016·The Mental Health Clinician·Robert W Schmidt, Meghan L Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.